(11-038) Oral Dexamethasone for Outpatient Management of Cytokine Release Syndrome in Patients Receiving Bispecific T-cell Engager Therapy for Multiple Myeloma
Wednesday, December 10, 2025
12:30 PM - 1:30 PM
Location: Bayside A, Level 1
Residency Program: Karmanos Cancer Center Residency Program Type: PGY2 (Oncology Pharmacy) Residency Program Location: Michigan
